By John Timmer, Ars Technica

A three-judge panel of a US Appeals Court lifted an injunction Friday against the National Institutes of Health’s revised policy on the funding of stem cell research. The new policy, which would open up research funding to many more human embryonic-stem-cell linesm or hESCs, attracted a lawsuit from researchers who focus on adult stem cells, who claimed that their chances of obtaining grants had been diminished.

That suit produced an injunction that would block the NIH from distributing funding for hESC work. The Appeals Court had previously stayed this injunction....